Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Cardiovascular Disease and Adiposity

Работ: 236

  1. ADAPTIVE CHANGES OF TISSUES: MORPHOLOGICAL AND FUNCTIONAL ANALYSIS

    Shoxrullo Saidov, Aziza Bekmurodova

    СтатьяRegulation of Appetite and ObesityZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  2. AGE-RELATED HISTOLOGICAL CHANGES IN CARDIAC MUSCLE TISSUE.

    Shoxrullo Saidov, Ramazon Abdikamolov

    СтатьяCardiac Fibrosis and RemodelingOpen MIND2026Цитирований: 0
    ABI

  3. AGE-RELATED HISTOLOGICAL CHANGES IN CARDIAC MUSCLE TISSUE.

    Shoxrullo Saidov, Ramazon Abdikamolov

    СтатьяCardiac Fibrosis and RemodelingZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  4. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

    Mukhammadali Jumayev

    СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  5. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

    Mukhammadali Jumayev

    СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  6. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

    Mukhammadali Jumayev

    СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  7. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

    Mukhammadali Jumayev

    СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  8. THE CURRENT RELEVANCE OF DILATIONAL CARDIOMYOPATHY.

    M.M.Sobirov, A.R.Atashev, R.Kh.Karimov.

    СтатьяCardiovascular Function and Risk FactorsOpen MIND2026Цитирований: 0
    ABI

  9. The Role of The Mitochondrial Carrier Mtch2 And Adipocyte Dysfunction in The Pathogenesis of Metabolic Disorders in Obesity

    Babadjanova Feruza Abdumalikovna, Abdurahmanov Azizbek Rustamovich, Uraimjonova Shoxsanam Adhamovna

    СтатьяAdipose Tissue and MetabolismThe American Journal of Medical Sciences and Pharmaceutical Research2026Цитирований: 0
    ABI

  10. THE CURRENT RELEVANCE OF DILATIONAL CARDIOMYOPATHY.

    M.M.Sobirov, A.R.Atashev, R.Kh.Karimov.

    СтатьяCardiovascular Function and Risk FactorsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  11. AORTA QON TOMIRI FAOLIYATINING FIZIOLOGIK XUSUSIYATLARI

    Saydaliyeva Rohatoy Zaylobidinovna, Toirov Botirjon Abduqodir o‘g‘li

    СтатьяEducation, Innovation and Language StudiesQo‘qon DPI Ilmiy xabarlar jurnali2026Цитирований: 0
    ABI

  12. CARDIORESPIRATORY RESPONSE TO PHYSICAL ACTIVITY IN ATRIAL FIBRILLATION PATIENTS BEFORE AND AFTER CATHETER ABLATION: A LITERATURE

    Akmaral Beisenbayeva, M Bekbossynova, F Bekmetova +2

    СтатьяAtrial Fibrillation Management and OutcomesBULLETIN OF SURGERY OF KAZAKHSTAN2026Цитирований: 0
    ABI

  13. CHARACTERISTICS OF LIPID AND RENAL INDICATORS IN PATIENTS WITH ISCHEMIC HEART DISEASE

    Gavhar Tulaboyeva, Shaxnoza Sobirova

    СтатьяCardiovascular Disease and AdiposityScientific and Innovative Therapy2026Цитирований: 0
    ABI

  14. A MODERN PERSPECTIVE ON CORONARY HEART DISEASE AND MYOCARDIAL INFARCTION IN YOUNG PEOPLE

    Sitora Khakimova, Dilafruz Ubaydova

    СтатьяAcute Myocardial Infarction ResearchScientific and Innovative Therapy2026Цитирований: 0
    ABI

  15. DYNAMICS OF VIOLATION OF MODERN HEMOSTASIS INDICATORS IN PERSISTENT FORM OF ATRIAL FIBRILLATION

    Nilufar Axmedova, M Rizaeva

    СтатьяAtrial Fibrillation Management and OutcomesScientific and Innovative Therapy2026Цитирований: 0
    ABI

  16. THE IMPACT OF METABOLIC SYNDROME AND ITS COMPONENTS ON CARDIOVASCULAR DISEASES

    Bekmatova Sh.K., Kazakov Kh.A., Zaripov S.B. +1

    СтатьяCardiovascular Disease and AdiposityZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  17. THE IMPACT OF METABOLIC SYNDROME AND ITS COMPONENTS ON CARDIOVASCULAR DISEASES

    Bekmatova Sh.K., Kazakov Kh.A., Zaripov S.B. +1

    СтатьяCardiovascular Disease and AdiposityZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  18. PHYSIOLOGICAL AND PATHOLOGICAL CHANGES OF THE CARDIOVASCULAR SYSTEM AND THEIR CLINICAL SIGNIFICANCE

    Kibriyeva Maxfirat, Norkulova Sumaya

    СтатьяHealthcare Systems and Public HealthZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  19. PHYSIOLOGICAL AND PATHOLOGICAL CHANGES OF THE CARDIOVASCULAR SYSTEM AND THEIR CLINICAL SIGNIFICANCE

    Kibriyeva Maxfirat, Norkulova Sumaya

    СтатьяHealthcare Systems and Public HealthZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  20. CLINICAL AND FUNCTIONAL FEATURES OF CARDIOMYOPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OPTIMIZED METABOLIC THERAPY

    Gulirano Khodjieva, Feruza Ikramova

    СтатьяCardiovascular Function and Risk FactorsScientific and Innovative Therapy2026Цитирований: 0
    ABI

  21. MORPHOLOGICAL PREDICTORS OF VASCULAR COMPLICATIONS IN METABOLIC SYNDROME: AN ANATOMICAL PERSPECTIVE

    Mehriniso Mengli kizi Begimova, Og'abek Khusan ugli Eshqovulov, kho'janbek Chori ugli Tursunov +2

    СтатьяCardiovascular Health and Disease PreventionZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  22. Coronary Artery Calcium Score and Severity of Ischemic Heart Disease in Obesity

    Z.Sh. Mamajonova, D. А. Egаmberdiyevа

    СтатьяCardiac Imaging and DiagnosticsAmerican Journal Of Biomedical Science & Pharmaceutical Innovation2026Цитирований: 0
    ABI

  23. MORPHOLOGICAL PREDICTORS OF VASCULAR COMPLICATIONS IN METABOLIC SYNDROME: AN ANATOMICAL PERSPECTIVE

    Mehriniso Mengli kizi Begimova, Og'abek Khusan ugli Eshqovulov, kho'janbek Chori ugli Tursunov +2

    СтатьяCardiovascular Health and Disease PreventionZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  24. ADVANCES IN CARDIOVASCULAR PHYSIOLOGY AND THEIR CLINICAL IMPLICATIONS

    Maxfirat Kibriyeva, Mashhura Boborahmatova

    СтатьяCardiovascular Function and Risk FactorsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  25. ADVANCES IN CARDIOVASCULAR PHYSIOLOGY AND THEIR CLINICAL IMPLICATIONS

    Maxfirat Kibriyeva, Mashhura Boborahmatova

    СтатьяCardiovascular Function and Risk FactorsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI